Logo

Almaden Genomics Advisory Board

Jun 02, 2023

Almaden Genomics has announced the inaugural members of its advisory board. Members include: Samir Cordy, senior VP for informatics at City of Hope Cancer Center; Rayna Herman, chief commercial officer of Eversana; serial entrepreneur Graham Hughes, a former executive at SAS Analytics and GE Healthcare; Adrian Lee, director of the Institute of Precision Medicine at the University of Pittsburgh and UPMC; and David Miller, operating partner of private equity firm GHO Capital and a former senior VP of global market access at Biogen.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.